TGFB1 and cancer: Our study found increased TGF-β pathway levels correlated with increased ANS expression in 17 of 25 (68%) cancer types, suggesting a potentially novel role for this signaling pathway in promoting tumor progression through intratumoral innervation, and warranting further mechanistic investigation in the future.